Imricor Medical Systems Inc (IMR) - Total Liabilities

Latest as of December 2025: AU$34.26 Million AUD ≈ $24.24 Million USD

Based on the latest financial reports, Imricor Medical Systems Inc (IMR) has total liabilities worth AU$34.26 Million AUD (≈ $24.24 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Imricor Medical Systems Inc long-term investment allocation to see how much of total assets are deployed in long-term investments.

Imricor Medical Systems Inc - Total Liabilities Trend (2016–2025)

This chart illustrates how Imricor Medical Systems Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see IMR current and non-current assets.

Imricor Medical Systems Inc Competitors by Total Liabilities

The table below lists competitors of Imricor Medical Systems Inc ranked by their total liabilities.

Company Country Total Liabilities
Shanghai Xuerong Bio-Technology Co Ltd
SHE:300511
China CN¥2.43 Billion
Shanghai Kindly Entrp Dvlp Grp
SHG:603987
China CN¥1.19 Billion
Zhejiang Giuseppe Garment Co Ltd
SHE:002687
China CN¥473.05 Million
WHA UTILITIES AND PO
BK:WHAUP-R
Thailand ฿17.49 Billion
Jiangsu Baoli Asphalt
SHE:300135
China CN¥586.32 Million
Jiangsu WELLE Environmental Co Ltd
SHE:300190
China CN¥4.41 Billion
Longmaster Information Tech
SHE:300288
China CN¥222.08 Million
Icon Offshore Bhd
KLSE:5255
Malaysia RM525.08 Million

Liability Composition Analysis (2016–2025)

This chart breaks down Imricor Medical Systems Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See IMR equity to assets ratio to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.47 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 2.97 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.75 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Imricor Medical Systems Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Imricor Medical Systems Inc (2016–2025)

The table below shows the annual total liabilities of Imricor Medical Systems Inc from 2016 to 2025.

Year Total Liabilities Change
2025-12-31 AU$34.26 Million
≈ $24.24 Million
+18.12%
2024-12-31 AU$29.00 Million
≈ $20.52 Million
+69.98%
2023-12-31 AU$17.06 Million
≈ $12.07 Million
+175.61%
2022-12-31 AU$6.19 Million
≈ $4.38 Million
+38.68%
2021-12-31 AU$4.46 Million
≈ $3.16 Million
-6.09%
2020-12-31 AU$4.75 Million
≈ $3.36 Million
+36.27%
2019-12-31 AU$3.49 Million
≈ $2.47 Million
+34.78%
2018-12-31 AU$2.59 Million
≈ $1.83 Million
-68.63%
2017-12-31 AU$8.25 Million
≈ $5.84 Million
+10.08%
2016-12-31 AU$7.50 Million
≈ $5.30 Million
--

About Imricor Medical Systems Inc

AU:IMR Australia Medical Devices
Market Cap
$469.33 Million
AU$663.30 Million AUD
Market Cap Rank
#12696 Global
#327 in Australia
Share Price
AU$1.85
Change (1 day)
+3.06%
52-Week Range
AU$1.34 - AU$2.20
All Time High
AU$2.79
About

Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company's products include Vision-MR Ablation Catheter 2.0, a MR-compatible cardiac ablation catheter; Vision-MR Diagnostic Catheter, a MR-compatib… Read more